CURX~~Huge insiders shareholders,,SEC Info? rendering: Initial Statement of Beneficial Ownership of Securities by an Insider
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Liu Chang
(Last) (First) (Middle)
C/O CURANEX PHARMACEUTICALS INC
2 JERICHO PLAZA SUITE 101 B
(Street)
JERICHO NY 11753
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
8/25/25 3. Issuer Name and Ticker or Trading Symbol
Curanex Pharmaceuticals Inc [ CURX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 4,870,020 D
Common Stock 2,340,000 I See footnote (1)
Common Stock 772,200 I See footnote (2)
Series A Preferred Stock 310,000 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
(1) These shares of common stock are held directly by Korovyev Hippo LLC, an entity in which the Reporting Person has the sole voting and investment power. By virtue of this relationship, the Reporting Person may be deemed to have the sole beneficial ownership of the securities held of record by Korovyev Hippo LLC.
(2) These shares of common stock are held directly by Liu and Company LLC, an entity in which the Reporting Person has the sole voting and investment power. By virtue of this relationship, the Reporting Person may be deemed to have the sole beneficial ownership of the securities held of record by Liu and Company LLC.
/s/ Chang Liu 9/2/25
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
?Top
AI
